Marcin Dzienis

784 total citations
19 papers, 126 citations indexed

About

Marcin Dzienis is a scholar working on Oncology, Molecular Biology and Otorhinolaryngology. According to data from OpenAlex, Marcin Dzienis has authored 19 papers receiving a total of 126 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Otorhinolaryngology. Recurrent topics in Marcin Dzienis's work include Cancer Immunotherapy and Biomarkers (10 papers), CAR-T cell therapy research (4 papers) and Head and Neck Cancer Studies (4 papers). Marcin Dzienis is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), CAR-T cell therapy research (4 papers) and Head and Neck Cancer Studies (4 papers). Marcin Dzienis collaborates with scholars based in Australia, United States and Brazil. Marcin Dzienis's co-authors include Victoria Atkinson, Pamela Mukhopadhyay, Orla M. Gannon, Lilia Merida de Long, Fiona Simpson, Mehlika Hazar-Rethinam, Ana Cristina Vargas, Nicholas A. Saunders, Liliana Endo‐Munoz and Matthew Foote and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Marcin Dzienis

13 papers receiving 122 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcin Dzienis Australia 5 86 61 42 21 13 19 126
Ramona Crescenzo United States 4 80 0.9× 52 0.9× 23 0.5× 12 0.6× 10 0.8× 5 116
Hayley Donnella United States 5 65 0.8× 33 0.5× 26 0.6× 20 1.0× 11 0.8× 6 112
Ingmar N. Bastian United States 2 68 0.8× 54 0.9× 29 0.7× 11 0.5× 29 2.2× 2 97
Adele Baker Australia 3 155 1.8× 60 1.0× 19 0.5× 9 0.4× 12 0.9× 3 186
Xuemei Zuo United States 5 69 0.8× 63 1.0× 53 1.3× 8 0.4× 24 1.8× 5 136
Farhana F. Merzoug United States 5 76 0.9× 60 1.0× 24 0.6× 24 1.1× 7 0.5× 8 112
Annemieke De Wilde Belgium 5 52 0.6× 39 0.6× 32 0.8× 4 0.2× 22 1.7× 7 102
Bianca J. Lee United States 4 60 0.7× 53 0.9× 33 0.8× 5 0.2× 17 1.3× 9 99
Alex Choi United States 2 90 1.0× 50 0.8× 18 0.4× 8 0.4× 19 1.5× 5 117

Countries citing papers authored by Marcin Dzienis

Since Specialization
Citations

This map shows the geographic impact of Marcin Dzienis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcin Dzienis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcin Dzienis more than expected).

Fields of papers citing papers by Marcin Dzienis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcin Dzienis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcin Dzienis. The network helps show where Marcin Dzienis may publish in the future.

Co-authorship network of co-authors of Marcin Dzienis

This figure shows the co-authorship network connecting the top 25 collaborators of Marcin Dzienis. A scholar is included among the top collaborators of Marcin Dzienis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcin Dzienis. Marcin Dzienis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
4.
Mason, Robert J., et al.. (2024). Immune-related colitis presenting with constipation. BMJ Case Reports. 17(7). e258940–e258940. 1 indexed citations
5.
White, Leigh, et al.. (2024). P641 Faecal calprotectin determines non-response to corticosteroids in patients with immune checkpoint inhibitor colitis. Journal of Crohn s and Colitis. 18(Supplement_1). i1217–i1218. 1 indexed citations
6.
Ladwa, Rahul, Janin Chandra, Wai-Ping Woo, et al.. (2024). A phase Ib study to assess the safety of the human papillomavirus DNA vaccine (AMV002) in combination with durvalumab for HPV-associated oropharyngeal squamous cell carcinoma. Frontiers in Oncology. 14. 1419258–1419258. 2 indexed citations
7.
Dzienis, Marcin, Juan Cundom, Anna Spreafico, et al.. (2024). Final Analysis of the Phase 4 KEYNOTE-B10 Study: First-Line (1L) Pembrolizumab (pembro) + Carboplatin (carbo) + Paclitaxel (pacli) for Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC). International Journal of Radiation Oncology*Biology*Physics. 118(5). e3–e4. 1 indexed citations
8.
Jackson, James E., et al.. (2023). Management of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma: a Contemporary Review. Current Oncology Reports. 25(5). 501–510. 2 indexed citations
9.
Dzienis, Marcin, et al.. (2022). Toxicity and response to ipilimumab and nivolumab in older patients with metastatic melanoma: A multicentre retrospective analysis. Pigment Cell & Melanoma Research. 35(6). 587–594. 3 indexed citations
10.
Dzienis, Marcin, et al.. (2022). Toxicity and response to ipilimumab and nivolumab in elderly patients with metastatic melanoma: A multicenter retrospective analysis.. Journal of Clinical Oncology. 40(16_suppl). e21540–e21540.
11.
Sanmugarajah, Jasotha, et al.. (2021). Safety and efficacy of telephone clinics during the COVID‐19 pandemic in the provision of care for patients with cancer. Internal Medicine Journal. 51(9). 1414–1419. 6 indexed citations
12.
Mason, Robert M., et al.. (2021). Multicentre retrospective assessment of toxicity and response to immunotherapy in elderly patients with metastatic melanoma.. Journal of Clinical Oncology. 39(15_suppl). 9565–9565.
13.
Gorayski, Peter & Marcin Dzienis. (2020). Complete clinical response of a neglected cutaneous melanoma with combined radiotherapy and immunotherapy: A case report. Journal of Medical Radiation Sciences. 68(1). 91–95. 1 indexed citations
14.
Dzienis, Marcin, et al.. (2019). Cetuximab associated dermal filler reaction. BMJ Case Reports. 12(8). e228882–e228882. 3 indexed citations
15.
Hazar-Rethinam, Mehlika, Lilia Merida de Long, Orla M. Gannon, et al.. (2015). RacGAP1 Is a Novel Downstream Effector of E2F7-Dependent Resistance to Doxorubicin and Is Prognostic for Overall Survival in Squamous Cell Carcinoma. Molecular Cancer Therapeutics. 14(8). 1939–1950. 34 indexed citations
16.
Gorayski, Peter, Marcin Dzienis, Matthew Foote, et al.. (2015). Radiotherapy utilization in BRAF mutation‐tested metastatic melanoma in the targeted therapy era. Asia-Pacific Journal of Clinical Oncology. 13(2). e117–e123. 3 indexed citations
17.
Hazar-Rethinam, Mehlika, Lilia Merida de Long, Orla M. Gannon, et al.. (2014). A Novel E2F/Sphingosine Kinase 1 Axis Regulates Anthracycline Response in Squamous Cell Carcinoma. Clinical Cancer Research. 21(2). 417–427. 35 indexed citations
18.
Dzienis, Marcin & Victoria Atkinson. (2014). Response rate to vemurafenib in patients with B-RAF-positive melanoma brain metastases. Melanoma Research. 24(4). 349–353. 30 indexed citations
19.
Dzienis, Marcin & Victoria Atkinson. (2013). Response rate to vemurafenib in BRAF-positive melanoma brain metastases.. Journal of Clinical Oncology. 31(15_suppl). 9081–9081. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026